BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35607801)

  • 1. Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
    Akıncı B; Atay D; Demir Yenigürbüz F; Akçay A; Öztürk G
    Exp Clin Transplant; 2022 Jul; 20(7):680-686. PubMed ID: 35607801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea.
    Yoon JH; Choi CW; Won JH
    Korean J Intern Med; 2021 Nov; 36(6):1261-1280. PubMed ID: 34555279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
    Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
    Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.
    Kumar S; DeLeve LD; Kamath PS; Tefferi A
    Mayo Clin Proc; 2003 May; 78(5):589-98. PubMed ID: 12744547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment.
    Özkan HA; Özkan SG
    Transfus Apher Sci; 2022 Feb; 61(1):103372. PubMed ID: 35101376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
    Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
    Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
    Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
    Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
    Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature.
    Hopps SA; Borders EB; Hagemann TM
    J Oncol Pharm Pract; 2016 Jun; 22(3):496-510. PubMed ID: 26126501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
    Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
    J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort.
    Dhir A; Wadhwa A; Haines H; Chewning J; Murthy S; Kim J; Beatty L; Mixon E; Fowler KB; Gage J; Meadows T; Goldman F
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e343-e348. PubMed ID: 35200220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).
    Yoon JH; Yoo KH; Sung KW; Jung CW; Kim JS; Hahn SM; Kang HJ; Lee JH; Im HJ; Ahn JS; Kook H; Cho B; Lee JW
    Bone Marrow Transplant; 2019 Aug; 54(8):1361-1368. PubMed ID: 30809031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese expert consensus on the diagnosis and management of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (2022)].
    Chinese Society of Hematology, Chinese Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):177-183. PubMed ID: 35405774
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
    Corbacioglu S; Kernan NA; Pagliuca A; Ryan RJ; Tappe W; Richardson PG
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1342-1349. PubMed ID: 32200121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplantation.
    Krimmel T; Williams LA
    Oncol Nurs Forum; 2008 Jan; 35(1):37-9. PubMed ID: 18192151
    [No Abstract]   [Full Text] [Related]  

  • 20. Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation.
    Richardson PG; Smith AR; Kernan NA; Lehmann L; Soiffer RJ; Ryan RJ; Tappe W; Grupp S
    Br J Haematol; 2020 Aug; 190(4):583-587. PubMed ID: 32157682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.